Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086684 · ClinicalTrials.gov registry record · Phase 4
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
A Phase 4 study, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- Terminated
- Registry status
- Phase 4
- Development phase
- 369
- Enrollment target
NCT00086684 is a Phase 4 study that was terminated before completion, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 369 participants.
The verdict
NCT00086684, a Phase 4 study, was terminated before completion, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 369 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of pentosan polysulfate sodium 100 mg once a day, pentosan polysulfate sodium 100 mg three times a day, and placebo for 24 weeks for the relief of bladder pain or discomfort associated with interstitial cystitis.
Interventions
- DRUG Placebo
- DRUG Pentosan polysulfate sodium 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2003-09 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086684
The ClinicalTrials.gov registry entry for NCT00086684 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00086684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086684 about?
NCT00086684 is a clinical study titled "Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis". The purpose of this study is to evaluate the safety and effectiveness of pentosan polysulfate sodium 100 mg once a day, pentosan polysulfate sodium 100 mg three times a day, and placebo for 24 weeks for the relief of bladder pain or discomfort associated with interstitial cystitis.
What is the current status of trial NCT00086684?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 369 participants. The study started on 2003-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00086684?
The interventions under investigation include: Placebo (DRUG), Pentosan polysulfate sodium 100 mg (DRUG).
Who is sponsoring clinical trial NCT00086684?
This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.